Table 3.

Transition probabilities from individual states at various follow-up times.

TP (95% CI)	At the1st year	At the 2 nd year	At the 3rd year	At the 4th year	At the 5th year
All cohorts
State 1 to State 2	0.044 (0.039–0.050)	0.069 (0.060–0.078)	0.082 (0.071–0.094)	0.089 (0.077–0.103)	0.093 (0.081–0.106)
State 1 to State 3	0.002 (0.002–0.003)	0.008 (0.005–0.010)	0.015 (0.011–0.020)	0.022 (0.017–0.030)	0.031 (0.023–0.041)
State 2 to State 1	0.329 (0.283–0.376)	0.511 (0.458–0.564)	0.611 (0.553–0.664)	0.663 (0.605–0.716)	0.690 (0.637–0.740)
State 2 to State 3	0.072 (0.054–0.094)	0.115 (0.087–0.152)	0.143 (0.106–0.188)	0.162 (0.124–0.212)	0.176 (0.134–0.227)
Diabetes cohort
State 1 to State 2	0.100 (0.075–0.133)	0.158 (0.117–0.207)	0.190 (0.141–0.247)	0.207 (0.152–0.270)	0.215 (0.157–0.283)
State 1 to State 3	0.006 (0.003–0.011)	0.021 (0.012–0.037)	0.041 (0.023–0.071)	0.064 (0.036–0.109)	0.088 (0.050–0.147)
State 2 to State 1	0.222 (0.154–0.318)	0.350 (0.249–0.473)	0.421 (0.306–0.553)	0.458 (0.339–0.588)	0.475 (0.353–0.603)
State 2 to State 3	0.095 (0.055–0.157)	0.161 (0.095–0.260)	0.209 (0.126–0.332)	0.247 (0.148–0.383)	0.278 (0.168–0.424)
Non-diabetes cohort
State 1 to State 2	0.036 (0.031–0.042)	0.056 (0.048–0.065)	0.067 (0.057–0.078)	0.073 (0.061–0.086)	0.076 (0.064–0.090)
State 1 to State 3	0.001 (0.001–0.002)	0.005 (0.003–0.007)	0.009 (0.006–0.014)	0.014 (0.010–0.021)	0.020 (0.013–0.029)
State 2 to State 1	0.349 (0.300–0.407)	0.543 (0.481–0.612)	0.651 (0.586–0.715)	0.710 (0.647–0.769)	0.740 (0.679–0.794)
State 2 to State 3	0.056 (0.038–0.082)	0.090 (0.062–0.130)	0.112 (0.077–0.159)	0.126 (0.086–0.180)	0.136 (0.093–0.194)

State 1 = Low risk of progression of CKD; State 2 = Moderately increased risk of progression of CKD; State 3 = High/Very High risk of progression of CKD. TP: transition probability; CKD: chronic kidney disease.